-
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
2020 May 24, 2:40pm | 2088Read More...Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector. Surface Oncology Inc (NASDAQ: SURF) was one of the biggest advancers of the week after it announced an oncology partnership with Merck & Co...
-
XpresSpa's Stock Skyrockets On Coronavirus Testing Contract
2020 May 22, 10:07am | 245Read More...XpresSpa (Nasdaq: XSPA) shares are trading sharply higher on Friday after the company announced it signed a contract to screen and test for COVID-19 at JFK International Air Terminal. The terminal will host nine separate testing rooms with a capacity to administer over 500 tests per day. XpresSpa...
-
Fauci Calls Moderna's Coronavirus Vaccine Candidate 'Quite Promising'
2020 May 22, 8:29am | 434Read More...Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is “cautiously optimistic” about Moderna Inc's (NASDAQ: MRNA) coronavirus vaccine candidate and told NPR that, if proven successful, it could be ready for use at the end of 2020. Moderna...
-
Pharmaceutical Supply Chains At Risk Of Emerging Cyber Threats
2020 May 21, 4:31pm | 1148Read More...As we enter a new decade in the digital age, data management has become a top priority for many high-value industries, especially pharmaceutical and healthcare companies. This sector strives to keep pace with the increased demand of COVID-19, as well as burgeoning technologies and the rapid...
-
AstraZeneca Receives Over $1B In BARDA Funding For Coronavirus Vaccine
2020 May 21, 9:48am | 588Read More...AstraZeneca plc (NYSE: AZN), which is collaborating with the Oxford University to develop a vaccine for SARS-CoV-2, announced Thursday a funding commitment from the U.S. Biomedical Advanced Research and Development Authority and also unveiled manufacturing plans. BARDA Extends Over $1B In...
-
CanSino Biologics Shares Rose 380% As COVID-19 Vaccine Promise Emerges
2020 May 21, 6:16am | 323Read More...CanSino Biologics Inc. (OTC: CASBF), a Chinese vaccine maker, has emerged as the rising star of the Hong Kong market, after its COVID-19 clinical trial application was approved by Health Canada, the country's federal health policy department. CanSino Biologics’ shares rose 380% in...
-
Citron Questions Inovio's 'Robust' Preclinical Coronavirus Vaccine Announcement, Sees 90% Downside Ahead
2020 May 20, 3:02pm | 511Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) said Wednesday that positive preclinical data for its DNA vaccine for the SARS-CoV-2 has been published in a peer-reviewed journal, sending its shares higher. Inovio's Preclinical Data News Stale? Following the announcement, short seller...
-
Benzinga Cannabis Capital Conference Presents: Al Harrington, NBA Star Turned Cannabis Impresario
2020 May 20, 12:02pm | 564Read More...Cannabis isn't a game for Al Harrington. The NBA veteran, who retired in 2015 after 16 seasons, takes the industry very seriously. He's also not one to mince words, which makes him an ideal speaker for the upcoming Virtual Benzinga Cannabis Capital Conference on June 1. For proof,...
-
Moderna Analyst Says Coronavirus Vaccine Candidate Has 65% Chance Of Success
2020 May 20, 12:00pm | 439Read More...Morgan Stanley, which recently named Moderna Inc (NASDAQ: MRNA) as one of the likeliest candidates to succeed in the coronavirus vaccine race, reviewed the interim Phase 1 data released by the company Monday. The Moderna Analyst Matthew Harrison maintained an Overweight rating on Moderna...
-
3 Women Shares Their Thoughts On Cannabis And Motherhood
2020 May 20, 11:59am | 3729Read More...By WeedMaps' Hannah Meadows, provided exclusively to Benzinga Cannabis. Though cannabis has made great strides in public perception the past couple of decades, certain groups are still wading through the waters of complete acceptance. The decision to partake in an edible or pull from a pipe...
-
Why Atossa Therapeutics Stock Is Trading Higher Today
2020 May 20, 11:26am | 153Read More...Atossa Therapeutics (NASDAQ: ATOS) shares are trading higher on Wednesday. The company announced "successful" in vitro testing results of AT-H201, which is Atossa's proprietary COVID-19 drug candidate. Atossa is a clinical stage pharmaceutical company operating in the U.S....
-
Inovio Publishes Positive Animal Testing Data For Coronavirus DNA Vaccine
2020 May 20, 9:20am | 484Read More...With the Street and experts divided on rival Moderna Inc's (NASDAQ: MRNA) recently released interim Phase 1 readout, Inovio Pharmaceuticals Inc (NASDAQ: INO) released positive preclinical data for its SARS-CoV-2 vaccine candidate INO-4800. What Happened? Pennsylvania-based Inovio announced...
-
Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market
2020 May 20, 8:33am | 1320Read More...The following article is sponsored by the clinical communications unit of investor relations firm Redington, Inc. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for informational purposes only. Since...
-
Moderna Vaccine Trial Missing Data To Judge Vaccine Efficacy, Experts Say
2020 May 20, 2:50am | 522Read More...Moderna, Inc.’s (NASDAQ: MRNA) claims on achieving a dose-dependent increase in immunogenicity in Phase 1 trials of its COVID-19 vaccine candidate, mRNA-1273, are not backed by sufficient data, according to vaccine experts. The Curious Case Of Antibodies Moderna made claims on Monday...
-
Checking In On Restaurants Amid The Coronavirus Lockdown: Timberloft Restaurant
2020 May 19, 5:08pm | 504Read More...Restaurants across a handful of states reopened their doors to limited seating over the past few days. Benzinga checked in with a handful of restaurants of different sizes to see how they are faring so far at a time when the COVID-19 pandemic remains a major overhang. This is part two. Timberloft...
